Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
ArticleAbstract: Background: The characterization of the first episode of psychosis and how it should be treated arePalabras claves:Antipsychotic, first episode psychosis, pharmacovigilance, polytherapy, psychotropic drugs, SchizophreniaAutores:Adrián LLerena, Aguilar E.J., Albacete A., Alonso-Solís A., Amoretti S., Baeza I., Balanzá-Martínez V., Bernardo M., Bioque M., Bobes J., Bulbena A., Butjosa A., Cabrera B., Castro-Fornieles J., Contreras F., Corripio I., Cuesta M.J., Díaz-Caneja M.C., Escartí M.J., García Bernardo E., García-Portilla M.P., Gassó P., González I., González-Pinto A., Grasa E., Hernandez M., Ibáñez Á., Lafuente A., Landín-Romero R., Lobo A., Mané A., Mas S., Mezquida G., Modrego F., Morales-Muñoz I., Parellada M., Rodriguez-Jimenez R., Ruiz P., Saiz-Ruiz J., Sánchez-Torres A.M., Sarró S., Segarra R., Tapia-Casellas C., Torrent C., Vieta E., Zabala Rabadán A.Fuentes:scopusUtility of the MoCA for cognitive impairment screening in long-term psychosis patients
ArticleAbstract: Cognitive impairment is a key feature in patients with psychotic disorders. The Montreal Cognitive APalabras claves:cognitive impairment, Cognitive screening, MoCA, Schizophrenia. psychosisAutores:Ballesteros A., Cuesta M.J., Fañanás L., García de Jalón E., Gil-Berrozpe G.J., Hernández R., Janda L., José Francisco López-Gil, Llano K., López-Ilundain J., Macaya P., Martínez-Parreño E., Moreno-Izco L., Papiol S., Peralta D., Peralta V., Ribeiro M., Rosero Á.S., Saiz H., Sánchez-Torres A.M.Fuentes:scopus